 | • レポートコード：QFJ1-4212 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、徐放性医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（徐放性医薬品、徐放性医薬品）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・徐放性医薬品の市場動向 ・企業の競争状況、市場シェア ・徐放性医薬品の種類別市場規模と予測2016-2027（徐放性医薬品、徐放性医薬品） ・徐放性医薬品の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・徐放性医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・徐放性医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・徐放性医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・徐放性医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・徐放性医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Mallinckrodt、Teva、Johnson & Johnson、Endo Pharmaceuticals、Purdue Pharma、Mylan、Hisamitsu Pharmaceutical、Sun Pharmaceutical Industries） ・結論 |
Drug delivery systems are engineered technologies for controlled release of drugs or to the targeted delivery of drugs. Drug delivery system is a kind of formulation that enables the administration of therapeutic agents in the body and improves its safety and efficacy by controlling the time, rate and place of drug release in the body. Most of the conventional oral products of drugs are formulated to release the active ingredient as soon as it is administered. Now the pattern has been changed to modified release dosage forms to achieve better therapeutic target. Extended release drugs is a type of dosage forms which allows a two-fold reduction in frequency of dosage administered in the body.
Market Analysis and Insights: Global Extended Release Drug Market
The global Extended Release Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Extended Release Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Extended Release Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Extended Release Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Extended Release Drug market.
Global Extended Release Drug Scope and Market Size
Extended Release Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Extended Release Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Sustained Release Drug
Controlled Release Drug
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extended Release Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sustained Release Drug
1.2.3 Controlled Release Drug
1.3 Market by Application
1.3.1 Global Extended Release Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Extended Release Drug Market Perspective (2016-2027)
2.2 Extended Release Drug Growth Trends by Regions
2.2.1 Extended Release Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Extended Release Drug Historic Market Share by Regions (2016-2021)
2.2.3 Extended Release Drug Forecasted Market Size by Regions (2022-2027)
2.3 Extended Release Drug Industry Dynamic
2.3.1 Extended Release Drug Market Trends
2.3.2 Extended Release Drug Market Drivers
2.3.3 Extended Release Drug Market Challenges
2.3.4 Extended Release Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extended Release Drug Players by Revenue
3.1.1 Global Top Extended Release Drug Players by Revenue (2016-2021)
3.1.2 Global Extended Release Drug Revenue Market Share by Players (2016-2021)
3.2 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Extended Release Drug Revenue
3.4 Global Extended Release Drug Market Concentration Ratio
3.4.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2020
3.5 Extended Release Drug Key Players Head office and Area Served
3.6 Key Players Extended Release Drug Product Solution and Service
3.7 Date of Enter into Extended Release Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extended Release Drug Breakdown Data by Type
4.1 Global Extended Release Drug Historic Market Size by Type (2016-2021)
4.2 Global Extended Release Drug Forecasted Market Size by Type (2022-2027)
5 Extended Release Drug Breakdown Data by Application
5.1 Global Extended Release Drug Historic Market Size by Application (2016-2021)
5.2 Global Extended Release Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Extended Release Drug Market Size (2016-2027)
6.2 North America Extended Release Drug Market Size by Type
6.2.1 North America Extended Release Drug Market Size by Type (2016-2021)
6.2.2 North America Extended Release Drug Market Size by Type (2022-2027)
6.2.3 North America Extended Release Drug Market Size by Type (2016-2027)
6.3 North America Extended Release Drug Market Size by Application
6.3.1 North America Extended Release Drug Market Size by Application (2016-2021)
6.3.2 North America Extended Release Drug Market Size by Application (2022-2027)
6.3.3 North America Extended Release Drug Market Size by Application (2016-2027)
6.4 North America Extended Release Drug Market Size by Country
6.4.1 North America Extended Release Drug Market Size by Country (2016-2021)
6.4.2 North America Extended Release Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Extended Release Drug Market Size (2016-2027)
7.2 Europe Extended Release Drug Market Size by Type
7.2.1 Europe Extended Release Drug Market Size by Type (2016-2021)
7.2.2 Europe Extended Release Drug Market Size by Type (2022-2027)
7.2.3 Europe Extended Release Drug Market Size by Type (2016-2027)
7.3 Europe Extended Release Drug Market Size by Application
7.3.1 Europe Extended Release Drug Market Size by Application (2016-2021)
7.3.2 Europe Extended Release Drug Market Size by Application (2022-2027)
7.3.3 Europe Extended Release Drug Market Size by Application (2016-2027)
7.4 Europe Extended Release Drug Market Size by Country
7.4.1 Europe Extended Release Drug Market Size by Country (2016-2021)
7.4.2 Europe Extended Release Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Extended Release Drug Market Size (2016-2027)
8.2 Asia-Pacific Extended Release Drug Market Size by Type
8.2.1 Asia-Pacific Extended Release Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Extended Release Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Extended Release Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Extended Release Drug Market Size by Application
8.3.1 Asia-Pacific Extended Release Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Extended Release Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Extended Release Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Extended Release Drug Market Size by Region
8.4.1 Asia-Pacific Extended Release Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Extended Release Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Extended Release Drug Market Size (2016-2027)
9.2 Latin America Extended Release Drug Market Size by Type
9.2.1 Latin America Extended Release Drug Market Size by Type (2016-2021)
9.2.2 Latin America Extended Release Drug Market Size by Type (2022-2027)
9.2.3 Latin America Extended Release Drug Market Size by Type (2016-2027)
9.3 Latin America Extended Release Drug Market Size by Application
9.3.1 Latin America Extended Release Drug Market Size by Application (2016-2021)
9.3.2 Latin America Extended Release Drug Market Size by Application (2022-2027)
9.3.3 Latin America Extended Release Drug Market Size by Application (2016-2027)
9.4 Latin America Extended Release Drug Market Size by Country
9.4.1 Latin America Extended Release Drug Market Size by Country (2016-2021)
9.4.2 Latin America Extended Release Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extended Release Drug Market Size (2016-2027)
10.2 Middle East & Africa Extended Release Drug Market Size by Type
10.2.1 Middle East & Africa Extended Release Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Extended Release Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Extended Release Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Extended Release Drug Market Size by Application
10.3.1 Middle East & Africa Extended Release Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Extended Release Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Extended Release Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Extended Release Drug Market Size by Country
10.4.1 Middle East & Africa Extended Release Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Extended Release Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Extended Release Drug Introduction
11.1.4 Pfizer Revenue in Extended Release Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Mallinckrodt
11.2.1 Mallinckrodt Company Details
11.2.2 Mallinckrodt Business Overview
11.2.3 Mallinckrodt Extended Release Drug Introduction
11.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2016-2021)
11.2.5 Mallinckrodt Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Extended Release Drug Introduction
11.3.4 Teva Revenue in Extended Release Drug Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Extended Release Drug Introduction
11.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Endo Pharmaceuticals
11.5.1 Endo Pharmaceuticals Company Details
11.5.2 Endo Pharmaceuticals Business Overview
11.5.3 Endo Pharmaceuticals Extended Release Drug Introduction
11.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2016-2021)
11.5.5 Endo Pharmaceuticals Recent Development
11.6 Purdue Pharma
11.6.1 Purdue Pharma Company Details
11.6.2 Purdue Pharma Business Overview
11.6.3 Purdue Pharma Extended Release Drug Introduction
11.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2016-2021)
11.6.5 Purdue Pharma Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Extended Release Drug Introduction
11.7.4 Mylan Revenue in Extended Release Drug Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Hisamitsu Pharmaceutical
11.8.1 Hisamitsu Pharmaceutical Company Details
11.8.2 Hisamitsu Pharmaceutical Business Overview
11.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction
11.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2016-2021)
11.8.5 Hisamitsu Pharmaceutical Recent Development
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Company Details
11.9.2 Sun Pharmaceutical Industries Business Overview
11.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction
11.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2016-2021)
11.9.5 Sun Pharmaceutical Industries Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sustained Release Drug
Table 3. Key Players of Controlled Release Drug
Table 4. Global Extended Release Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Extended Release Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Extended Release Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Extended Release Drug Market Share by Regions (2016-2021)
Table 8. Global Extended Release Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Extended Release Drug Market Share by Regions (2022-2027)
Table 10. Extended Release Drug Market Trends
Table 11. Extended Release Drug Market Drivers
Table 12. Extended Release Drug Market Challenges
Table 13. Extended Release Drug Market Restraints
Table 14. Global Extended Release Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Extended Release Drug Market Share by Players (2016-2021)
Table 16. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2020)
Table 17. Ranking of Global Top Extended Release Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Extended Release Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Extended Release Drug Product Solution and Service
Table 21. Date of Enter into Extended Release Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Extended Release Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Extended Release Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Extended Release Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Extended Release Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Extended Release Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Extended Release Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Extended Release Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Extended Release Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Extended Release Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Extended Release Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Extended Release Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Extended Release Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Extended Release Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Extended Release Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Extended Release Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Extended Release Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Extended Release Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Extended Release Drug Product
Table 64. Pfizer Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Mallinckrodt Company Details
Table 67. Mallinckrodt Business Overview
Table 68. Mallinckrodt Extended Release Drug Product
Table 69. Mallinckrodt Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 70. Mallinckrodt Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Extended Release Drug Product
Table 74. Teva Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Extended Release Drug Product
Table 79. Johnson & Johnson Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Endo Pharmaceuticals Company Details
Table 82. Endo Pharmaceuticals Business Overview
Table 83. Endo Pharmaceuticals Extended Release Drug Product
Table 84. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 85. Endo Pharmaceuticals Recent Development
Table 86. Purdue Pharma Company Details
Table 87. Purdue Pharma Business Overview
Table 88. Purdue Pharma Extended Release Drug Product
Table 89. Purdue Pharma Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 90. Purdue Pharma Recent Development
Table 91. Mylan Company Details
Table 92. Mylan Business Overview
Table 93. Mylan Extended Release Drug Product
Table 94. Mylan Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 95. Mylan Recent Development
Table 96. Hisamitsu Pharmaceutical Company Details
Table 97. Hisamitsu Pharmaceutical Business Overview
Table 98. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 99. Hisamitsu Pharmaceutical Recent Development
Table 100. Sun Pharmaceutical Industries Company Details
Table 101. Sun Pharmaceutical Industries Business Overview
Table 102. Sun Pharmaceutical Industries Extended Release Drug Product
Table 103. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
Table 104. Sun Pharmaceutical Industries Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Extended Release Drug Market Share by Type: 2020 VS 2027
Figure 2. Sustained Release Drug Features
Figure 3. Controlled Release Drug Features
Figure 4. Global Extended Release Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Extended Release Drug Report Years Considered
Figure 9. Global Extended Release Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Extended Release Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Extended Release Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Extended Release Drug Market Share by Regions (2022-2027)
Figure 13. Global Extended Release Drug Market Share by Players in 2020
Figure 14. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2020
Figure 16. Global Extended Release Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Extended Release Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Extended Release Drug Market Share by Type (2016-2027)
Figure 20. North America Extended Release Drug Market Share by Application (2016-2027)
Figure 21. North America Extended Release Drug Market Share by Country (2016-2027)
Figure 22. United States Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Extended Release Drug Market Share by Type (2016-2027)
Figure 26. Europe Extended Release Drug Market Share by Application (2016-2027)
Figure 27. Europe Extended Release Drug Market Share by Country (2016-2027)
Figure 28. Germany Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Extended Release Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Extended Release Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Extended Release Drug Market Share by Region (2016-2027)
Figure 38. China Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Extended Release Drug Market Share by Type (2016-2027)
Figure 46. Latin America Extended Release Drug Market Share by Application (2016-2027)
Figure 47. Latin America Extended Release Drug Market Share by Country (2016-2027)
Figure 48. Mexico Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Extended Release Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Extended Release Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Extended Release Drug Market Share by Country (2016-2027)
Figure 54. Turkey Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 58. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 59. Teva Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 61. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 62. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 64. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 65. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の徐放性コーティング剤市場規模・現状・予測（2021年-2027年） Sustained Release Coatings are sustained release drug delivery systems for the sustained release of drugs in the body over a prolonged period of time, particularly in order to maintain therapeutic levels. Market Analysis and Insights: Global Sustained Release Coatings Market The global Sustained Rel…- 世界の抗コリン薬市場規模・現状・予測（2021年-2027年） Anticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, digestion, and several others. The drug i…
- 世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
- 世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年） Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria. Market Analysis and Insights: Global Acute Hepatic Porphyria Drug Market The global Acute Hepatic Porphyria Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
- 放出制御窒素肥料のグローバル市場調査 2019年 The global Controlled-Release Nitrogen Fertilizer market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Controlled-Release Nitrogen Fertilizer volume and value at global level, regional level and company …